Sign Up to like & get
recommendations!
1
Published in 2020 at "JCI insight"
DOI: 10.1172/jci.insight.140971
Abstract: Purinergic modulators, such as dipyridamole, target multiple pathways that have been implicated in COVID-19 pathogenesis, and thus the therapeutic benefit of these should be explored.
read more here.
Keywords:
drug purinergic;
old drug;
receptor blockade;
purpose old ... See more keywords